ArticleFrontiers in medicine2026
The prognostic value of combining MNA-SF nutritional status and probable sarcopenia for 90-day readmission in elderly inpatients with multimorbidity.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the predictive value of nutritional status combined with Probable sarcopenia assessment for all-cause readmission of elderly inpatients with multimorbidity within 90 days after discharge. Methods: In this single-centre retrospective cohort study, a total of 244 patients aged ≥65 years admitted to our hospital from January 2023 to March 2025 were selected as the research subjects. Abnormal nutritional status (malnutrition or risk of malnutrition, MNA-SF ≤11) and probable sarcopenia (per modified EWGSOP2-based criteria) were assessed within 48 h of admission, and patients were divided into a readmission group (59 cases) and a non-readmission group (185 cases) according to whether they were readmitted within 90 days after discharge. Results: The age of patients in the readmission group was significantly higher than that in the non-readmission group ( Conclusion: In this single-center retrospective cohort, the coexistence of abnormal nutritional status (MNA-SF ≤11) and probable sarcopenia was independently associated with higher odds of 90-day readmission in elderly hospitalized patients with multimorbidity. Larger prospective multicenter studies are needed to validate the combined assessment and determine whether targeted interventions reduce readmission.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.